Jacquelyn Sumer
Compliance Officer bij CULLINAN THERAPEUTICS, INC.
Vermogen: 2 M $ op 30-06-2024
Actieve functies van Jacquelyn Sumer
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
| CULLINAN THERAPEUTICS, INC. | Compliance Officer | 15-08-2022 | - |
| Algemeen Adviseur | 15-08-2022 | - | |
| Bedrijfssecretaris | 15-08-2022 | - |
Loopbaan van Jacquelyn Sumer
Eerdere bekende functies van Jacquelyn Sumer
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
| CELGENE | Directeur/Bestuurslid | 01-05-2017 | 01-07-2018 |
| Corporate Officer/Principal | 01-05-2017 | 01-07-2018 | |
| BRISTOL-MYERS SQUIBB COMPANY | Corporate Officer/Principal | - | - |
| GENOCEA BIOSCIENCES, INC. | Compliance Officer | 01-02-2021 | - |
| Algemeen Adviseur | 01-02-2021 | - |
Opleiding van Jacquelyn Sumer
| Duke University School of Law | Graduate Degree |
| Bucknell University | Undergraduate Degree |
Statistieken
Internationaal
| Verenigde Staten | 7 |
Operationeel
| Compliance Officer | 2 |
| General Counsel | 2 |
| Corporate Officer/Principal | 2 |
Sectoraal
| Health Technology | 5 |
| Consumer Services | 3 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
| Beursgenoteerde bedrijven | 3 |
|---|---|
| GENOCEA BIOSCIENCES, INC. | Health Technology |
| BRISTOL-MYERS SQUIBB COMPANY | Health Technology |
| CULLINAN THERAPEUTICS, INC. | Health Technology |
| Bedrijven in privébezit | 1 |
|---|---|
Celgene Corp.
 Celgene Corp. BiotechnologyHealth Technology Celgene Corp. is an integrated global biopharmaceutical company, which engages in the discovery, development and commercialization of therapies for the treatment of cancer and inflammatory diseases. Its primary commercial stage products include Revlimid, Pomalyst, Imnovid, Otezla, Abraxane, and Vidaza. The company was founded by David Stirling and Sol Barer in 1986 and is headquartered in Summit, NJ. | Health Technology |
- Beurs
- Insiders
- Jacquelyn Sumer
- Ervaring
